Dr. Debadatta Mohapatra is a postdoctoral researcher at Leslie Dan Faculty of Pharmacy, University of Toronto, Canada. He has completed his Ph.D. from the Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi, India in 2023. His research primarily focuses on Quality-by-Design-based formulation development and characterization of various novel drug delivery systems, especially solid dispersion, transferosome, nanoemulsion, carbon dots, hydrogel, and phytoformulations for therapeutic benefits. He is currently involved in evaluating the therapeutic efficacy of various small-molecule drugs and novel formulations for the treatment of neovascular age-related macular degeneration, and has collaborated on multiple projects focused on ocular neovascularization. He has a core competency in analytical and bioanalytical method development and validation, quality control, and standardization of herbal drugs, pharmacokinetics, cancer therapeutics, and in vitro/in vivo pharmacological activity evaluations. Dr. Mohapatra has published numerous peer-reviewed research articles in various high-impact journals and has presented his work at national and international conferences. He is an active member of Indian Pharmaceutical Association (IPA). In addition to his academic and research endeavors, Dr. Mohapatra actively collaborates with industries, academia, and research institutions to bridge the gap between academic research and practical applications.
Dr. Debadatta Mohapatra is a postdoctoral researcher at Leslie Dan Faculty of Pharmacy, University of Toronto, Canada. He has completed his Ph.D. from the Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi, India in 2023. His research primarily focuses on Quality-by-Design-based formulation development and characterization of various novel drug delivery systems, especially solid dispersion, transferosome, nanoemulsion, carbon dots, hydrogel, and phytoformulations for therapeutic benefits. He is currently involved in evaluating the therapeutic efficacy of various small-molecule drugs and novel formulations for the treatment of neovascular age-related macular degeneration, and has collaborated on multiple projects focused on ocular neovascularization. He has a core competency in analytical and bioanalytical method development and validation, quality control, and standardization of herbal drugs, pharmacokinetics, cancer therapeutics, and in vitro/in vivo pharmacological activity evaluations. Dr. Mohapatra has published numerous peer-reviewed research articles in various high-impact journals and has presented his work at national and international conferences. He is an active member of Indian Pharmaceutical Association (IPA). In addition to his academic and research endeavors, Dr. Mohapatra actively collaborates with industries, academia, and research institutions to bridge the gap between academic research and practical applications.